and rubella by vaccination, mumps, Prevention of measles
Conditions
Brief summary
To measure the level of specific immunity, measured as level of measles neutralising antibodies by plaque-reduction neutralisation test 1-3 years after routine MMR vaccination at 4 years of age
Detailed description
• Level of specific immunity, measured as level of measles neutralising antibodies by plaque-reduction neutralisation test at least 1 year after MMR2. Level of specific immunity, measured as level of IgG against measles, mumps, and rubella at least 1 year after MMR2.
Interventions
Sponsors
Rigshospitalet
Eligibility
Sex/Gender
All
Age
0 Years to 17 Years
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| To measure the level of specific immunity, measured as level of measles neutralising antibodies by plaque-reduction neutralisation test 1-3 years after routine MMR vaccination at 4 years of age | — |
Secondary
| Measure | Time frame |
|---|---|
| • Level of specific immunity, measured as level of measles neutralising antibodies by plaque-reduction neutralisation test at least 1 year after MMR2. Level of specific immunity, measured as level of IgG against measles, mumps, and rubella at least 1 year after MMR2. | — |
Outcome results
None listed